120 results on '"Khuu T"'
Search Results
2. Silicon-integrated La2NiO4+δ-Based Valencechange Memristive Devices with Neuromorphic Programming Capabilities
3. Factors Affecting Decision to Participate Bancassurance: Evidence from Individual Customers in the South of Vietnam
4. La2NiO4+δ-based resistive switching memories integrated on silicon wafers
5. Survival for Combined Heart-Lung Transplant (HLT) Recipients over the Past 30 Years
6. Past is Not Prologue - Immune Function Assay Results as a Predictor of Malignancy Post-Heart Transplant (HT)
7. Use of Donor HCV NAT Positive Hearts: Expanding the Donor Pool?
8. Use of dd-cfDNA in Real World Practice: Single Center Experience
9. Use of dd-cfDNA in Multiorgan Transplantation
10. Is There a Mortality “Weekend Effect” in Cardiac Transplantation - A Single Center Experience?
11. Is There a Mortality “Weekend Effect” in Cardiac Transplantation?
12. Utilization of PHS Increased Risk Donors in Lung Transplant Reduces Median Waitlist Time without Reducing Survival
13. How Much Do Farmers Expect to Implement for Traceability? Evidence From a Double-Bound Choices Experiment of Vietnamese Shrimp Aquaculture.
14. Reduced Readmissions with Enoxaparin Bridging for Subtherapeutic INR in MCS
15. Optimizing Immunosuppression: Steroid Weaning Strategies in Heart Transplant (HT)
16. Improving Utility of MELD-XI Prognostication in Heart Transplant
17. Direct Acting Oral Anticoagulant Utilization, Safety and Efficacy in Heart Transplant (HT)
18. Survival in Re-Do Heart Transplant: Does Dual Organ Allocation Make a Difference?
19. Dynamic Phenomapping and HLA Class I and II Antibodies for Heart Transplant Outcomes
20. LVAD Patients with CKD: Are Two Organs Better than One?
21. Abdominopelvic Dissemination of Leiomyomas Following Minimally Invasive Surgery and Tissue Morcellation – a Case Series
22. Cluster Analysis and Dynamic Phenomapping to Guide Clinical Management After Heart Transplantation
23. Close to the Heart: Increasing Geographic Distance from Transplanting Center Associated with Increased Incidence of Graft Failure and Mortality Following Heart Transplant
24. Steps towards Personalization of Clinical Care in Era of Precision Medicine. Time Dependent Immune Phenomapping in Heart Transplantation and Emergence of Anti-HLA Class I and II Antibodies
25. (1130) - Survival in Re-Do Heart Transplant: Does Dual Organ Allocation Make a Difference?
26. (1101) - Improving Utility of MELD-XI Prognostication in Heart Transplant
27. (1075) - Dynamic Phenomapping and HLA Class I and II Antibodies for Heart Transplant Outcomes
28. (785) - Reduced Readmissions with Enoxaparin Bridging for Subtherapeutic INR in MCS
29. (274) - LVAD Patients with CKD: Are Two Organs Better than One?
30. (266) - Direct Acting Oral Anticoagulant Utilization, Safety and Efficacy in Heart Transplant (HT)
31. (209) - Optimizing Immunosuppression: Steroid Weaning Strategies in Heart Transplant (HT)
32. Complement-Fixing Donor-Specific HLA Antibodies Detected By Novel C3d Assay Are Associated With Antibody Mediated Rejection in Heart Transplant Recipients
33. Time Course of Immunosuppression Minimization and HLA Class I and Class II Antibody Emergence in Heart Transplantation
34. 187 - Abdominopelvic Dissemination of Leiomyomas Following Minimally Invasive Surgery and Tissue Morcellation – a Case Series
35. Differential Mitochondrial Gene Expression in Patients Undergoing MCSD Implantation
36. Novel Nomogram of the Immune Response After Heart Transplantation
37. Cardiac Retransplantation: How Far Have We Come?
38. Incidence and Importance of Donor-Specific HLA Antibody in Heart Transplant Recipients
39. A novel machine learning approach to predict the export price of seafood products based on competitive information: The case of the export of Vietnamese shrimp to the US market.
40. Comparing Bortezomib to Traditional Therapies for Antibody-Mediated Rejection (AMR): Out with the Old?
41. Outcomes of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Post Heart Transplant (HT)
42. Influence of Pre-Transplant Chronic Kidney Disease (CKD) on Adult Heart Transplant (HT) Outcomes
43. Post-Heart Transplant (HT) Survival for Adult Congenital Heart Disease (ACHD)
44. Outcomes of Adult Heart (HT) Versus Heart-Kidney (H+K) Transplant: Influence of CKD (Chronic Kidney Disease) Stage
45. Does Gender Influence Survival of Heart Transplant (HT) Recipients Bridged with LVAD Support?
46. Outcomes of Heart Transplant (HT) Recipients Bridged with ECMO
47. Outcomes in Patients with Ischemic Cardiomyopathy (ICM) Post-Heart Transplant (HT) by Era
48. Reduced HLA Class II Antibody Response to Proteasome Inhibition
49. 300 Low Absolute Lymphocyte Count at Six Months Post-Heart Transplantation Predictive of Late-Onset CMV
50. Thrombotic Microangiopathy With Tacrolimus/Sirolimus-Based GVHD Prophylaxis Regimen in Patients Undergoing Hematopoietic Stem Cell Transplant
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.